Mucosal immune system: the regulatory action of probiotics



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The evidence of the beneficial effects of dairy products on the intestinal microflora was given for the first time in 1908 by I.I. Mechnikov in the famous article «A few words about the sour milk». Since that time probiotics - the living microorganisms for regulation of intestinal microbiota are the case of interest. Interactions between the probiotics and macroorganism are very complex and include a network of genes receptors, signaling molecules and a variety of other factors that determine the natural course of the disease.

Full Text

Restricted Access

About the authors

N G Astafieva

SBEI HPE Saratov Medical University by named after V.I. Rasumovsky of the Ministry of Health and Social Development of the Russian Federation

Email: astang@mail.ru

I V Gamova

SBEI HPE Saratov Medical University by named after V.I. Rasumovsky of the Ministry of Health and Social Development of the Russian Federation

E N Udovitchenko

SBEI HPE Saratov Medical University by named after V.I. Rasumovsky of the Ministry of Health and Social Development of the Russian Federation

I A Perfilova

SBEI HPE Saratov Medical University by named after V.I. Rasumovsky of the Ministry of Health and Social Development of the Russian Federation

D Y Kobzev

Leeds Trinity University

І Ae Michailova

SBEI HPE Saratov Medical University by named after V.I. Rasumovsky of the Ministry of Health and Social Development of the Russian Federation

References

  1. Ohshima Y. Mucosal Immunity and the Onset of Allergic Disease. Allergology International. 2013, v. 62, p. 279-289.
  2. Киселева Е.П. Акцептивный иммунитет - основа симбиотических отношений. Инфекция и иммунитет. 2015, № 2, с. 113-130.
  3. Holmgren J., Czerkinsky C. Mucosal immunity and vaccines. Nature Medicine Supplement. 2005, v. 11, р. 45-53.
  4. Р.М Хаитов. Физиология иммунной системы. М., ВИНИТИ РАН. 2001, 224 с.
  5. Ярилин А.А. Иммунология. М., «ГЭОТАР-Медиа». 2010, 752 с.
  6. Kiyono H., Fukuyama S. NALT-versus Peyer’s-patch-mediated mucosal immunity. Nat. Rev. Immunol. 2004, v. 4, p. 699-710.
  7. Neutra M.R., Mantis N.J., Kraehenbuhl J.P. Collaboration of epithelial cells with organized mucosal lymphoid tissues. Nature Immunology. 2001, v. 2, p. 1004-1009.
  8. Gebert A., Steinmetz I., Fassbender S. et al. Antigen transport into Peyer’s patches: increased uptake by constant numbers of M-cells. Am. J. Pathol. 2004, v. 164, p. 65-72.
  9. Zheng R., Yang Q. The Role of the γδ T-cell in Allergic Diseases. J. Immunol. Res. 2014, p. 1-8.
  10. Arrieta M.C., Stiemsma L.T., Amenyogbe N. et al. The intestinal microbiome in early life: health and disease. Front. Immunol. 2014, v. 5, p. 427.
  11. Min Y.W., Rhee P.L. The Role of Microbiota on the Gut Immunology. Clin. Ther. 2015, v. 5, p. 968-975.
  12. Kato L.M., Kawamoto S., Maruya M., Fagarasan S. The role of the adaptive immune system in regulation of gut microbiota. Immunol. Rev. 2014, p. 67-75.
  13. Haahtela T., Holgate S., Pawankar R. et al. The biodiversity hypothesis and allergic disease: world allergy organization position statement. World Allergy Organ J. 2013, p. 3.
  14. Daley D. The evolution of the hygiene hypothesis: the role of early-life exposures to viruses and microbes and their relationship to asthma and allergic diseases Curr. Opin. Allergy Clin. Immunol. 2014, v. 14, p. 390-396.
  15. Russell S.L., Finlay B.B. The impact of gut microbes in allergic diseases. Curr. Opin. Gastroenterol. 2012, p. 563-569.
  16. Hemarajata P., Versalovic J. Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation. Therap. Adv. Gastroenterol. 2013, p. 39-51.
  17. Bäckhed F., Ding H., Wang T. et al. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. USA. 2004, v. 101, p. 15718-15723.
  18. Огородова Л.М., Говорун В.М., Федосенко С.В. и соавт. Особенности микробиоты кишечника у больных хронической обструктивной болезнью легких. Бюллетень сибирской медицины. 2014, № 5,с. 55-61.
  19. Киселева Е.П. Акцептивный иммунитет - основа симбиотических отношений. Инфекция и иммунитет. 2015, № 2, с. 113-130.
  20. Киселева Е.П. Врожденный иммунитет - основа симбиотических взаимоотношений. Биохимия. 2014, № 12, с. 1564-1579.
  21. Климович В.Б. Актуальные проблемы эволюционной иммунологии. Журнал эволюционной биохимии и физиологии. 2002, № 5, с. 442-451.
  22. Medzhitov R., Janeway C.A. Decoding the patterns of self and nonselfby innate immune system. Science. 2002, v. 296, p. 298-300.
  23. McFall-Ngai M. Care for the community. Nature. 2007, v. 445, p. 153-153.
  24. Ohshima Y. Mucosal Immunity and the Onset ofAllergic Disease Allergology International. 2013, v. 62, p. 279-289.
  25. Pulverer G., Ko H.L., Beuth J. Immunomodulating effects of antibiotics influencing digestive flora. Pathol. Biol. (Paris) 1993, v. 41, p. 753-758.
  26. Tojo R., Suarez A., Clemente M.G. et al. Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis. World J. Gastroenterol. 2014, v. 20, p. 15163-15176.
  27. Quigley E.M. Prebiotics and probiotics: their role in the management of gastrointestinal disorders in adults. Nutr. Clin. Pract. 2012, v. 27, p. 195200.
  28. Хромова C.C., Шкопоров А.Н., Ефимов Б.А. и соавт. Микрофлора кишечника и механизмы иммунорегуляции. Вопросы детской диетологии. 2005, № 1, с. 92-96.
  29. Андреева И.В. Потенциальные возможности применения пробиотиков в клинической практике. Клин. микробиол. антимикроб-химиотер. 2006, № 2, с. 151-172.
  30. Osborn D.A., Sinn J.K. Probiotics in infants for prevention of allergy. Cochrane Database Syst. Rev. 2013, CD006474.
  31. Foisy M., Boyle R.J., Chalmers J.R. et al. The prevention of eczema in infants and children: an overview of Cochrane and non-Cochrane reviews. Evid. Based Child Health. 2011, v. 6, p. 1322-1339.
  32. Guarner F., Khan A.G., Garisch J. et al. World Gastroenterology Organization Global Guidelines: probiotics and prebiotics October 2011. J. Clin. Gastroenterol. 2012, v. 46, p. 468-481.
  33. Toh Z.Q., Anzela A., Tang M.L. et al. Probiotic Therapy as a Novel Approach for Allergic Disease. Front Pharmacol. 2012, v. 3, p. 171.
  34. Quigley E.M. Prebiotics and probiotics: their role in the management of gastrointestinal disorders in adults. Nutr. Clin. Pract. 2012, v. 27, p. 195-200.
  35. De Vrese M., Winkler P., Rautenberg P. et al. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. Clinical Nutrition. 2005, v. 24, p. 481-491.
  36. Калюжин О.В. Безопасность и физиологичность действия пробиотиков как средств иммунокоррекции. Росс. Аллергол. Журн. 2013, № 3, c. 45-56.
  37. Коденцова В.М. Необходимость использования витаминно-минеральных комплексов в лечебном питании в медицинских организациях и учреждениях соцзащиты. Симпозиум «Школа диетолога». XV Всероссийский конгресс диетологов и нутрициологов «Здоровое питание: от фундаментальных исследований к инновационным технологиям». М., «Фармарус Принт Медиа». 2014, № 3, 92 c.
  38. Nurmatov U., Devereux G., Sheikh A. Nutrients and foods for the primary prevention of asthma and allergy: systematic review and meta-analysis. J. Allergy Clin. Immunol. 2011, v. 127, p. 724-733.
  39. Winkler P., de Vrese M., Laue Ch. et al. Effect of a dietary supplement containing probiotic bacteria plus vitamins and minerals on common cold infections and cellular immune parameters. Int. J. Clin. Pharmacol. Ther. 2005, v. 43, p. 318-326.
  40. Leyer G.J., Li S., Mubasher M.E. et al. Probiotic Effects on Cold and Influenza-Like Symptom Incidence and Duration in Children. Pediatrics. 2009, v. 124, p. 172-179.
  41. Kang E.J., Kim S.Y., Hwang I.H. et al. The effect of probiotics on prevention of common cold: a meta-analysis of randomized controlled trial studies. Korean J. Fam. Med. 2013, v. 34, p. 2-10.
  42. Hao Q., Dong B.R., Wu T. Probiotics for preventing acute upper respiratory tract infections. Cochrane Database Syst. Rev. 2015, CD006895.
  43. Wang M.F., Lin H.C., Wang Y.Y. et al. Treatment of perennial allergic rhinitis with lactic acid bacteria. Pediatr. Allergy Immunol. 2004, v. 15, p. 152-158.
  44. Карпова Е.П., Тулупов Д.А. Бактериальные биопленки в оториноларингологии. Эффективная фармакотерапия. 2012, № 1, c. 6-9.
  45. Мезенцева О.Ю., Медведева О.А., Воробьева А.А. Роль биопленок в патогенезе хронического бактериального риносинусита. Вестник оториноларингологии. 2014, № 2, с. 79-81.
  46. Fokkens W.J., Lund V.J., Mullol J. et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology. 2015, v. 50, p. 1-12.
  47. Papadopoulos N.G., Agache I., Bavbek S. et al. Research needs in allergy: an EAACI position paper, in collaboration with EFA. Clin. Transl. Allergy. 2012, v. 2, p. 21.
  48. Clinical Use of Probiotics in Pediatric Allergy (CUPPA): A World Allergy Organization Position Paper. Wrrld Allergy Organ J. 2012, v. 5, p. 148-167.
  49. Fiocchi A., Pawankar R., Cuello-Garcia C. et al. World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Probiotics. World Allergy Organ J. 2015, v. 8, p. 4.
  50. Pelucchi C., Chatenoud L., Turati F. et al. Probiotics supplementation during pregnancy or infancy for the prevention of atopic dermatitis: a meta-analysis. Epidemiology. 2012, v. 23, p. 402-414.
  51. Zajac A., Adams A.S., Turner J.H. A systematic review and meta-analysis of probiotics for the treatment of allergic rhinitis Int. Forum Allergy Rhinol. 2015, v. 5, p. 524-532.
  52. Chapman T.J., Georas S.N. Regulatory tone and mucosal immunity in asthma. Int. Immunopharmacol. 2014, v. 23, p. 330-336.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright © Pharmarus Print Media, 2015



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies